Free Trial

CannaPharmaRX 9/1/2023 Earnings Report

CannaPharmaRX logo
$0.0055 +0.00 (+25.00%)
As of 04/8/2025 10:07 AM Eastern

CannaPharmaRX EPS Results

Actual EPS
-$0.02
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

CannaPharmaRX Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

CannaPharmaRX Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Remove Ads

CannaPharmaRX Earnings Headlines

PSIQ Profile Solutions, Inc.
This almost killed Elon Musk (chilling details emerge)
Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.
CannaPharmaRX, Inc. (CPMD)
CannaPharmaRx to Host Investor Conference Call
See More CannaPharmaRX Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like CannaPharmaRX? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CannaPharmaRX and other key companies, straight to your email.

About CannaPharmaRX

CannaPharmaRX (OTCMKTS:CPMD) operates in the cannabis industry in Canada. It evaluates, negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada.

View CannaPharmaRX Profile

More Earnings Resources from MarketBeat